The Emerging Cancer Immunotherapy Market Driven by Rising Prevalence of Cancer The cancer immunotherapy market is witnessing significant growth driven by rising prevalence of cancer. Cancer immunotherapy utilizes the body's own immune system to fight cancer either by helping immune cells identify cancer cells or by expanding the number of immune cells to strengthen the body's response against cancer cells. The global cancer immunotherapy market is estimated to be valued at US$ 6358.39 Mn in 2024 and is expected to exhibit a CAGR of 26% over the forecast period 2024 to 2031. Get more insights: Cancer Immunotherapy Market (https://articlescad.com/cancer-immunotherapy-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-precision-m-10100.html) #CoherentMarketInsights #CancerImmunotherapyMarket #ImmuneCheckpointInhibitors #Vaccines #AdoptiveCellTherapies #ImmuneSystemModulators #MonoclonalAntibodies